Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D000638 |
Amiodarone |
Amiodarone results in increased expression of TFAP2C mRNA | increases expression | 19774075
|
C006632 |
arsenic trioxide |
arsenic trioxide results in decreased expression of TFAP2C mRNA | decreases expression | 15761015
|
D017638 |
Asbestos, Crocidolite |
Asbestos, Crocidolite results in increased expression of TFAP2C mRNA | increases expression | 18687144
|
C014347 |
decitabine |
[decitabine co-treated with TFAP2C protein] results in increased expression of ESR1 mRNA | affects cotreatment|increases expression | 19458056
|
C014347 |
decitabine |
[decitabine co-treated with TFAP2C protein] results in increased expression of RERG mRNA | affects cotreatment|increases expression | 19458056
|
C014347 |
decitabine |
[decitabine co-treated with trichostatin A] promotes the reaction [TFAP2C protein binds to ESR1 promoter] | affects binding|affects cotreatment|increases reaction | 19458056
|
C014347 |
decitabine |
[decitabine co-treated with trichostatin A] promotes the reaction [TFAP2C protein results in increased expression of ESR1 mRNA] | affects cotreatment|increases expression|increases reaction | 19458056
|
C014347 |
decitabine |
decitabine results in increased expression of TFAP2C mRNA | increases expression | 16367923
|
C014347 |
decitabine |
TFAP2C protein promotes the reaction [[decitabine co-treated with trichostatin A] results in increased expression of ESR1 mRNA] | affects cotreatment|increases expression|increases reaction | 19458056
|
C014347 |
decitabine |
TFAP2C protein promotes the reaction [[decitabine co-treated with trichostatin A] results in increased expression of RERG mRNA] | affects cotreatment|increases expression|increases reaction | 19458056
|
D017239 |
Paclitaxel |
Paclitaxel results in decreased expression of TFAP2C mRNA | decreases expression | 19682730
|
C059514 |
resveratrol |
resveratrol results in increased localization of and results in increased activity of TFAP2C protein | increases activity|increases localization | 16488535
|
D013749 |
Tetrachlorodibenzodioxin |
SRC protein promotes the reaction [Tetrachlorodibenzodioxin affects the expression of TFAP2C mRNA] | affects expression|increases reaction | 14708085
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin affects the expression of TFAP2C mRNA | affects expression | 14708085
|
C012589 |
trichostatin A |
[decitabine co-treated with trichostatin A] promotes the reaction [TFAP2C protein binds to ESR1 promoter] | affects binding|affects cotreatment|increases reaction | 19458056
|
C012589 |
trichostatin A |
[decitabine co-treated with trichostatin A] promotes the reaction [TFAP2C protein results in increased expression of ESR1 mRNA] | affects cotreatment|increases expression|increases reaction | 19458056
|
C012589 |
trichostatin A |
TFAP2C protein promotes the reaction [[decitabine co-treated with trichostatin A] results in increased expression of ESR1 mRNA] | affects cotreatment|increases expression|increases reaction | 19458056
|
C012589 |
trichostatin A |
TFAP2C protein promotes the reaction [[decitabine co-treated with trichostatin A] results in increased expression of RERG mRNA] | affects cotreatment|increases expression|increases reaction | 19458056
|
C012589 |
trichostatin A |
[trichostatin A co-treated with TFAP2C protein] results in increased expression of ESR1 mRNA | affects cotreatment|increases expression | 19458056
|
C012589 |
trichostatin A |
[trichostatin A co-treated with TFAP2C protein] results in increased expression of RERG mRNA | affects cotreatment|increases expression | 19458056
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
3.18 | 11752688 14514962 15322242 |
MESH:D058186 |
Acute Kidney Injury |
|
resveratrol |
4.09 | 16538975 |
MESH:D000230 |
Adenocarcinoma |
|
arsenic trioxide |
2.33 | 19825857 11798837 |
MESH:D000236 |
Adenoma |
|
resveratrol |
3.44 | 15688382 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
3.71 | 16835633 |
MESH:D000544 |
Alzheimer Disease |
|
resveratrol |
2.61 | 16183991 16162502 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
3.17 | 11748828 |
MESH:D001145 |
Arrhythmias, Cardiac |
|
Amiodarone |
4.03 | 18218290 20041841 18057881 |
MESH:D001169 |
Arthritis, Experimental |
|
resveratrol |
3.64 | 17115116 |
MESH:D050197 |
Atherosclerosis |
|
resveratrol |
3.40 | 17967414 16873680 |
MESH:D001281 |
Atrial Fibrillation |
|
Amiodarone |
4.08 | 19698954 18651412 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Amiodarone |
16.84 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
arsenic trioxide |
16.84 | 16206674 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
16.84 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
4.17 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.91 | 15746008 |
MESH:D001859 |
Bone Neoplasms |
|
Paclitaxel |
4.83 | 15867366 |
MESH:D002545 |
Brain Ischemia |
|
resveratrol |
4.62 | 17600658 |
MESH:D001943 |
Breast Neoplasms |
|
decitabine |
2.03 | 19208741 18320071 |
MESH:D001943 |
Breast Neoplasms |
|
Paclitaxel |
2.03 | 16244791 18223236 16273361 18234424 15136595 18323546 16115903 11325840 |
MESH:D001943 |
Breast Neoplasms |
|
resveratrol |
2.03 | 16393696 17534123 17651959 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
2.03 | 20435547 |
MESH:D002051 |
Burkitt Lymphoma |
|
arsenic trioxide |
4.59 | 11589617 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.99 | 16835633 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
arsenic trioxide |
4.94 | 15553829 15073043 16217749 14691202 11135700 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Paclitaxel |
4.94 | 16313753 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
resveratrol |
4.94 | 19321006 16227395 |
MESH:D018827 |
Carcinoma, Lewis Lung |
|
resveratrol |
4.93 | 16675471 |
MESH:D002291 |
Carcinoma, Papillary |
|
arsenic trioxide |
5.25 | 19014326 |
MESH:D018288 |
Carcinoma, Small Cell |
|
arsenic trioxide |
4.35 | 12490120 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
decitabine |
5.12 | 19215824 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
resveratrol |
5.12 | 16227395 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.49 | 18850075 16120746 18670907 |
MESH:D002311 |
Cardiomyopathy, Dilated |
|
Amiodarone |
2.96 | 19225199 15710769 |
MESH:D002318 |
Cardiovascular Diseases |
|
resveratrol |
3.63 | 15458977 |
MESH:D002341 |
Carotid Artery Thrombosis |
|
Amiodarone |
5.42 | 18974383 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.38 | 16835633 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.19 | 8697196 15668235 16354765 12621046 15340226 |
MESH:D003092 |
Colitis |
|
resveratrol |
4.43 | 16474422 |
MESH:D003110 |
Colonic Neoplasms |
|
decitabine |
4.07 | 17616700 |
MESH:D003110 |
Colonic Neoplasms |
|
resveratrol |
4.07 | 16338953 |
MESH:D015179 |
Colorectal Neoplasms |
|
arsenic trioxide |
4.99 | 20501625 |
MESH:D015179 |
Colorectal Neoplasms |
|
decitabine |
4.99 | 18981723 |
MESH:D015179 |
Colorectal Neoplasms |
|
Paclitaxel |
4.99 | 18802399 |
MESH:D015179 |
Colorectal Neoplasms |
|
resveratrol |
4.99 | 16550006 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.27 | 17141729 14669216 |
MESH:D003327 |
Coronary Disease |
|
resveratrol |
3.89 | 16507316 |
MESH:D023903 |
Coronary Restenosis |
|
arsenic trioxide |
4.47 | 12609071 |
MESH:D019465 |
Craniofacial Abnormalities |
|
arsenic trioxide |
2.53 | 10525206 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
2.53 | 10048152 20055451 15322242 |
MESH:D016757 |
Death, Sudden, Cardiac |
|
arsenic trioxide |
4.36 | 15213294 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
resveratrol |
3.97 | 16873680 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.71 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
resveratrol |
4.18 | 16286809 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Amiodarone |
4.05 | 15265979 18218290 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
4.05 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.93 | 11462148 |
MESH:D004487 |
Edema |
|
resveratrol |
7.68 | 8985016 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
7.68 | 12711302 11000095 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
4.28 | 18230668 15322242 16714409 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
resveratrol |
4.31 | 17872969 |
MESH:D004701 |
Endocrine Gland Neoplasms |
|
decitabine |
15.32 | 19294695 |
MESH:D004701 |
Endocrine Gland Neoplasms |
|
trichostatin A |
15.32 | 19294695 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
3.25 | 10568697 9294722 |
MESH:D020345 |
Enterocolitis, Necrotizing |
|
resveratrol |
5.16 | 17923197 |
MESH:D004938 |
Esophageal Neoplasms |
|
arsenic trioxide |
4.93 | 12903497 |
MESH:D004938 |
Esophageal Neoplasms |
|
Paclitaxel |
4.93 | 16481741 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
3.19 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
Amiodarone |
8.81 | 14986274 |
MESH:D005234 |
Fatty Liver |
|
arsenic trioxide |
8.81 | 15073043 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.76 | 11858732 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
3.25 | 20067830 |
MESH:D005706 |
Gallbladder Neoplasms |
|
arsenic trioxide |
4.54 | 16904648 |
MESH:D005909 |
Glioblastoma |
|
trichostatin A |
3.98 | 18801729 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.97 | 10696789 |
MESH:D006258 |
Head and Neck Neoplasms |
|
decitabine |
3.64 | 19215824 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
2.44 | 11294989 10048152 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.58 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
Amiodarone |
9.58 | 15265979 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
9.58 | 16120746 15340226 12621046 |
MESH:D006561 |
Herpes Simplex |
|
resveratrol |
4.52 | 16876885 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.42 | 16354765 15340226 8697196 16959395 18606429 |
MESH:D006937 |
Hypercholesterolemia |
|
Amiodarone |
10.14 | 9751232 8137927 |
MESH:D006937 |
Hypercholesterolemia |
|
resveratrol |
10.14 | 17188708 |
MESH:D006949 |
Hyperlipidemias |
|
resveratrol |
4.29 | 16873680 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
1.98 | 18850075 18670907 |
MESH:D017379 |
Hypertrophy, Left Ventricular |
|
resveratrol |
4.53 | 17488730 |
MESH:D007037 |
Hypothyroidism |
|
Amiodarone |
4.82 | 18020914 17991464 |
MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
resveratrol |
4.95 | 17600658 |
MESH:D007248 |
Infertility, Male |
|
decitabine |
3.35 | 17581917 |
MESH:D007249 |
Inflammation |
|
resveratrol |
5.44 | 16366677 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
5.44 | 12878042 12200463 |
MESH:D007251 |
Influenza, Human |
|
resveratrol |
4.92 | 16624496 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.58 | 16580747 |
MESH:D007938 |
Leukemia |
|
arsenic trioxide |
6.81 | 15070760 |
MESH:D007938 |
Leukemia |
|
decitabine |
6.81 | 18980019 19235587 |
MESH:D015459 |
Leukemia-Lymphoma, Adult T-Cell |
|
arsenic trioxide |
4.04 | 12560223 17077332 |
MESH:D007948 |
Leukemia, Monocytic, Acute |
|
arsenic trioxide |
4.64 | 16972261 |
MESH:D015464 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
|
arsenic trioxide |
3.60 | 14633726 |
MESH:D007951 |
Leukemia, Myeloid |
|
arsenic trioxide |
10.41 | 19077051 |
MESH:D007951 |
Leukemia, Myeloid |
|
decitabine |
10.41 | 18454857 19117987 17236224 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
arsenic trioxide |
6.48 | 16968895 16467208 17050201 20471514 19850784 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
decitabine |
6.48 | 19010910 18704418 18206229 17679729 19387464 18460780 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
trichostatin A |
6.48 | 18206229 |
MESH:D015477 |
Leukemia, Myelomonocytic, Chronic |
|
decitabine |
5.84 | 18055864 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
arsenic trioxide |
8.29 | 16823087 16966277 15622746 17712046 19075265 11468182 17649720 16331271 15213294 17217047 17107899 19225113 16891316 16330433 16112521 11161223 15748426 19642359 19035177 12712474 15336539 12679006 9834237 17869043 12018890 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
resveratrol |
8.29 | 16087638 |
MESH:D015458 |
Leukemia, T-Cell |
|
arsenic trioxide |
4.63 | 16882451 |
MESH:D008064 |
Lipidoses |
|
Amiodarone |
3.68 | 15342952 17567588 |
MESH:D008080 |
Liposarcoma |
|
Paclitaxel |
5.08 | 17353645 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
1.24 | 12878042 |
MESH:D008113 |
Liver Neoplasms |
|
arsenic trioxide |
7.93 | 14682389 |
MESH:D008113 |
Liver Neoplasms |
|
resveratrol |
7.93 | 19812893 20405173 19321006 19073162 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
7.93 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
arsenic trioxide |
6.27 | 20377131 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
6.27 | 12151625 |
MESH:D008133 |
Long QT Syndrome |
|
Amiodarone |
8.81 | 17391786 15350150 11989578 |
MESH:D008133 |
Long QT Syndrome |
|
arsenic trioxide |
8.81 | 15213294 |
MESH:D008171 |
Lung Diseases |
|
Amiodarone |
3.53 | 12587719 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Amiodarone |
4.85 | 18516814 |
MESH:D055370 |
Lung Injury |
|
Asbestos, Crocidolite |
4.33 | 17365036 |
MESH:D008175 |
Lung Neoplasms |
|
arsenic trioxide |
2.35 | 11798837 19825857 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
2.35 | 11884234 19555203 |
MESH:D008223 |
Lymphoma |
|
decitabine |
3.58 | 19470736 |
MESH:D016393 |
Lymphoma, B-Cell |
|
resveratrol |
4.56 | 17088997 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Paclitaxel |
9.67 | 14749477 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
resveratrol |
9.67 | 14749477 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
resveratrol |
4.58 | 15688416 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
resveratrol |
3.25 | 8985016 11606380 |
MESH:D008545 |
Melanoma |
|
decitabine |
7.70 | 17785578 16505122 |
MESH:D008545 |
Melanoma |
|
Paclitaxel |
7.70 | 12040289 12025231 16342250 |
MESH:D008545 |
Melanoma |
|
resveratrol |
7.70 | 17992120 |
MESH:D008545 |
Melanoma |
|
trichostatin A |
7.70 | 16505122 |
MESH:D008654 |
Mesothelioma |
|
Asbestos, Crocidolite |
3.26 | 16966607 18303189 16166281 |
MESH:D008659 |
Metabolic Diseases |
|
resveratrol |
4.62 | 17112576 |
MESH:D009101 |
Multiple Myeloma |
|
arsenic trioxide |
24.54 | 19417148 19549372 14977855 11468182 15949261 |
MESH:D009101 |
Multiple Myeloma |
|
decitabine |
24.54 | 18172295 |
MESH:D009101 |
Multiple Myeloma |
|
Paclitaxel |
24.54 | 14749477 |
MESH:D009101 |
Multiple Myeloma |
|
resveratrol |
24.54 | 16267019 16490592 17164350 14749477 17935668 17049120 |
MESH:D009101 |
Multiple Myeloma |
|
trichostatin A |
24.54 | 18172295 |
MESH:D009134 |
Muscular Atrophy, Spinal |
|
resveratrol |
5.21 | 17962980 |
MESH:D009181 |
Mycoses |
|
Amiodarone |
5.28 | 17974566 12754197 |
MESH:D009182 |
Mycosis Fungoides |
|
arsenic trioxide |
5.05 | 18349030 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
arsenic trioxide |
7.92 | 16882451 16105982 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
decitabine |
7.92 | 19157545 16882708 19010910 18608210 |
MESH:D009203 |
Myocardial Infarction |
|
resveratrol |
3.11 | 16456233 17188708 17015251 17125593 16317513 16525036 |
MESH:D017202 |
Myocardial Ischemia |
|
resveratrol |
9.66 | 17015251 17125593 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
9.66 | 12213967 |
MESH:D009205 |
Myocarditis |
|
resveratrol |
5.10 | 17322642 |
MESH:D009361 |
Neoplasm Invasiveness |
|
arsenic trioxide |
4.24 | 16624393 |
MESH:D009362 |
Neoplasm Metastasis |
|
Paclitaxel |
3.33 | 15867366 |
MESH:D009369 |
Neoplasms |
|
decitabine |
2.81 | 17925555 19116145 19470736 |
MESH:D009374 |
Neoplasms, Experimental |
|
resveratrol |
4.31 | 8985016 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
3.49 | 14600291 |
MESH:D009436 |
Neural Tube Defects |
|
arsenic trioxide |
3.26 | 10525206 |
MESH:D019636 |
Neurodegenerative Diseases |
|
resveratrol |
4.01 | 17652729 |
MESH:D020078 |
Neurogenic Inflammation |
|
resveratrol |
4.66 | 17929310 |
MESH:D010014 |
Osteolysis |
|
Paclitaxel |
5.32 | 15867366 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
resveratrol |
4.52 | 17513867 |
MESH:D010051 |
Ovarian Neoplasms |
|
arsenic trioxide |
11.92 | 12452020 19769630 16624393 |
MESH:D010051 |
Ovarian Neoplasms |
|
decitabine |
11.92 | 19259094 19331143 |
MESH:D010051 |
Ovarian Neoplasms |
|
Paclitaxel |
11.92 | 11161223 |
MESH:D010051 |
Ovarian Neoplasms |
|
trichostatin A |
11.92 | 19331143 |
MESH:D010190 |
Pancreatic Neoplasms |
|
arsenic trioxide |
9.20 | 15580305 |
MESH:D010190 |
Pancreatic Neoplasms |
|
decitabine |
9.20 | 19294695 |
MESH:D010190 |
Pancreatic Neoplasms |
|
trichostatin A |
9.20 | 19294695 |
MESH:D010235 |
Paraganglioma |
|
arsenic trioxide |
4.42 | 19927285 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.62 | 12520081 |
MESH:D010995 |
Pleural Diseases |
|
Asbestos, Crocidolite |
5.20 | 10923243 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.84 | 18163543 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
resveratrol |
10.74 | 16679765 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
10.74 | 11222880 11896295 11399792 11118676 |
MESH:D055728 |
Primary Myelofibrosis |
|
decitabine |
13.47 | 17616702 |
MESH:D055728 |
Primary Myelofibrosis |
|
trichostatin A |
13.47 | 17616702 |
MESH:D011471 |
Prostatic Neoplasms |
|
arsenic trioxide |
2.14 | 19131511 |
MESH:D011471 |
Prostatic Neoplasms |
|
Paclitaxel |
2.14 | 17172428 17136230 16729912 16356831 |
MESH:D011471 |
Prostatic Neoplasms |
|
resveratrol |
2.14 | 15767336 17804756 17718901 17636462 16731767 17675339 |
MESH:D011471 |
Prostatic Neoplasms |
|
trichostatin A |
2.14 | 18798265 19789329 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Amiodarone |
6.15 | 11597910 12832656 12490602 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Asbestos, Crocidolite |
6.15 | 15814490 17975199 17322281 17365031 |
MESH:D051436 |
Renal Insufficiency, Chronic |
|
resveratrol |
5.96 | 16325855 |
MESH:D015427 |
Reperfusion Injury |
|
resveratrol |
3.37 | 16314181 17520802 16317513 17058453 15827377 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
4.12 | 18990726 |
MESH:D012208 |
Rhabdomyosarcoma |
|
decitabine |
4.66 | 19155313 |
MESH:D012512 |
Sarcoma, Ewing's |
|
arsenic trioxide |
4.24 | 16646077 |
OMIM:609620 |
SHORT QT SYNDROME 1 |
|
Amiodarone |
5.42 | 18724381 |
MESH:D012878 |
Skin Neoplasms |
|
resveratrol |
6.05 | 8985016 15837718 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
6.05 | 16192470 |
MESH:D013274 |
Stomach Neoplasms |
marker/mechanism |
|
| 16367923 |
MESH:D013274 |
Stomach Neoplasms |
|
arsenic trioxide |
3.60 | 17007042 |
MESH:D013274 |
Stomach Neoplasms |
|
decitabine |
3.60 | 19037991 |
MESH:D013274 |
Stomach Neoplasms |
|
Paclitaxel |
3.60 | 18396642 18506536 |
MESH:D013276 |
Stomach Ulcer |
|
Amiodarone |
3.55 | 18087811 |
OMIM:601367 |
STROKE, ISCHEMIC |
|
resveratrol |
4.71 | 16321402 |
MESH:D013610 |
Tachycardia |
|
Amiodarone |
4.57 | 11238279 |
MESH:D017180 |
Tachycardia, Ventricular |
|
Amiodarone |
4.47 | 19225199 |
MESH:D024801 |
Tauopathies |
|
Paclitaxel |
5.15 | 16930453 |
MESH:D013959 |
Thyroid Diseases |
|
Amiodarone |
13.34 | 19731979 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
13.34 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
arsenic trioxide |
7.93 | 19014326 |
MESH:D013964 |
Thyroid Neoplasms |
|
decitabine |
7.93 | 17967635 |
MESH:D013971 |
Thyrotoxicosis |
|
Amiodarone |
5.17 | 19584973 18020914 |
MESH:D014062 |
Tongue Neoplasms |
|
resveratrol |
4.44 | 16227395 |
MESH:D016171 |
Torsades de Pointes |
|
Amiodarone |
11.41 | 17467628 11989578 |
MESH:D016171 |
Torsades de Pointes |
|
arsenic trioxide |
11.41 | 15213294 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
arsenic trioxide |
5.51 | 20435036 12973940 12845720 11780464 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
decitabine |
5.51 | 19087683 17616700 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
resveratrol |
4.33 | 17473185 |
MESH:D014594 |
Uterine Neoplasms |
|
resveratrol |
4.42 | 17044934 |
MESH:D014604 |
Uveal Neoplasms |
|
decitabine |
5.29 | 17785578 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.97 | 12125929 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
resveratrol |
4.61 | 17488730 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.62 | 15886252 |